Iovance Biotherapeutics Inc (IOVA)

[badgerkid]

GMH, I think the company offered all they could regarding revenue growth and projections and did so carefully so as to not get caught in a revenue trap for Q2. The anlaysts will likely stay conservative in their estimates as well, but one or two may surprise with high side estimates. As mentioned, revenue from Amtagvi is recorded when infused, but trying to pin down the exact timing is still challenging during this ramp up. Which side will it fall on for Q2 or Q3 is fluid right now, but I think by the end of Q3, we may see actual revenue guidance for Q4.

I for one am glad they kept it vague, it may allow me a chance to add a few more shares at bargain prices while I gather in a few more investing dollars.

Good luck to the longs.